A detailed history of Signaturefd, LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 221 shares of MIRM stock, worth $10,375. This represents 0.0% of its overall portfolio holdings.

Number of Shares
221
Previous 180 22.78%
Holding current value
$10,375
Previous $6,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$33.68 - $44.74 $1,380 - $1,834
41 Added 22.78%
221 $8,000
Q2 2024

Jul 29, 2024

BUY
$23.57 - $34.85 $235 - $348
10 Added 5.88%
180 $6,000
Q1 2024

May 03, 2024

SELL
$24.92 - $30.02 $99 - $120
-4 Reduced 2.3%
170 $4,000
Q4 2023

Jan 31, 2024

BUY
$27.14 - $34.93 $108 - $139
4 Added 2.35%
174 $5,000
Q2 2023

Aug 01, 2023

SELL
$23.51 - $30.09 $117 - $150
-5 Reduced 2.86%
170 $4,000
Q1 2023

Apr 28, 2023

BUY
$19.19 - $24.1 $2,916 - $3,663
152 Added 660.87%
175 $4,000
Q4 2022

Jan 27, 2023

BUY
$17.59 - $23.83 $404 - $548
23 New
23 $0

Others Institutions Holding MIRM

About Mirum Pharmaceuticals, Inc.


  • Ticker MIRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,751,700
  • Market Cap $1.73B
  • Description
  • Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...
More about MIRM
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.